Evidence map›Paper›PMID 33465404›Full record

ArticleCellular signalling2021

Cdk1 phosphorylation negatively regulates the activity of Net1 towards RhoA during mitosis.

Arzu Ulu, Wonkyung Oh, Yan Zuo, Jeffrey A Frost

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Cellular signalling, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Arzu UluDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, 6431 Fannin St., Houston, TX 77030, USA; Division of Biomedical Sciences, School of Medicine, University of California, Irvine, CA 92507, USA.
Wonkyung OhDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, 6431 Fannin St., Houston, TX 77030, USA; Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, USA.
Yan ZuoDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, 6431 Fannin St., Houston, TX 77030, USA.
Jeffrey A FrostDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, 6431 Fannin St., Houston, TX 77030, USA. Electronic address: jeffrey.a.frost@uth.tmc.edu.
The University of Texas Health Science Center at Houston · US

Funding

Role of the RhoGEF Net1 in breast cancer cell motility and metastasisR01CA172129 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI FROST, JEFFREY A. · 2014 to 2018
$1.6M
Rho GEFs in Cellular Proliferation and TransformationR01CA116356 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI FROST, JEFFREY A. · 2007 to 2011
$1.4M
ERK/MAP KINASE SIGNALLING PATHWAYSF32GM016926 · NIGMS · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI FROST, JEFFREY A · 1994 to 1996
–
NCI NIH HHS R01 CA116356NCI NIH HHS R01 CA172129NIGMS NIH HHS F32 GM016926
6 · The paper itself

Abstract

The Neuroepithelial transforming gene 1 (Net1) is a RhoA subfamily guanine nucleotide exchange factor that is overexpressed in a number of cancers and contributes to cancer cell motility and proliferation. Net1 also plays a Rho GTPase independent role in mitotic progression, where it promotes centrosomal activation of Aurora A and Pak2, and aids in chromosome alignment during prometaphase. To understand regulatory mechanisms controlling the mitotic function of Net1, we examined whether it was phosphorylated by the mitotic kinase Cdk1. We observed that Cdk1 phosphorylated Net1 on multiple sites in its N-terminal regulatory domain and C-terminus in vitro. By raising phospho-specific antibodies to two of these sites, we also demonstrated that both endogenous and transfected Net1 were phosphorylated by Cdk1 in cells. Substitution of the major Cdk1 phosphorylation sites with aliphatic or acidic residues inhibited the interaction of Net1 with RhoA, and treatment of metaphase cells with a Cdk1 inhibitor increased Net1 activity. Cdk1 inhibition also increased Net1 localization to the plasma membrane and stimulated cortical F-actin accumulation. Moreover, Net1 overexpression caused spindle polarity defects that were reduced in frequency by acidic substitution of the major Cdk1 phosphorylation sites. These data indicate that Cdk1 phosphorylates Net1 during mitosis and suggest that this negatively regulates its ability to signal to RhoA and alter actin cytoskeletal organization.

Indexed as

MitosisActin CytoskeletonActinsCDC2 Protein KinaseCell MembraneHeLa CellsHumansMutagenesis, Site-DirectedOncogene ProteinsPhosphorylationProtein StabilityrhoA GTP-Binding ProteinRNA InterferenceRNA, Small InterferingSpindle ApparatusActinsCDC2 Protein KinaseCDK1 protein, humanNET1 protein, humanOncogene ProteinsrhoA GTP-Binding ProteinRHOA protein, humanRNA, Small InterferingCdk1F-actinMitosisNet1RhoASpindle polarity

Identifiers

PMID33465404
PMCPMC7878416
OpenAlexW3125451082

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.